妊娠期高血压疾病患者药学监护流程的建立与实践

Establishment and practice of pharmaceutical care process for patients with hypertensive disorder complicating pregnancy

目的探讨妊娠期高血压疾病患者药学监护流程的建立与实践效果。方法选取100例妊娠期高血压疾病患者作为研究对象,根据随机数字表法分为观察组和对照组,每组50例。对照组由医师及护士采用常规治疗及护理,观察组在对照组基础上接受临床药师药学监护。比较两组患者护理前后血压水平,用药依从性,不良妊娠结局发生情况。结果护理后,两组患者的收缩压及舒张压水平均低于治疗前,且观察组的收缩压及舒张压水平均明显低于对照组,差异具有统计学意义(P<0.05)。观察组的用药依从性良好率76.00%明显高于对照组的94.00%,差异具有统计学意义(P<0.05)。观察组不良妊娠结局发生率14.00%明显低于对照组的36.00%,差异具有统计学意义(P<0.05)。结论在妊娠期高血压疾病患者治疗中建立规范的药学监护流程干预,可有效控制患者的血压,并能提高患者的用药依从性,减少不良妊娠结局的发生。

Objective To discuss the establishment and practice of pharmaceutical care process for patients with hypertensive disorder complicating pregnancy.Methods A total of 100 patients with hypertensive disorder complicating pregnancy as study subjects were divided into observation group and control group according to random numerical table,with 50 cases in each group.The control group received routine treatment and nursing by doctors and nurses,while the observation group received pharmaceutical care by clinical pharmacists on the basis of the control group.The blood pressure before and after nursing,medication compliance and occurrence of adverse outcomes were compared between the two groups.Results After nursing,the systolic and diastolic blood pressure of the two groups were lower than those before treatment,and the observation group were obviously lower than those of the control group,and the difference was statistically significant(P<0.05).The medication compliance rate 76.00%of the observation group was obviously higher than 94.00%of the control group,and the difference was statistically significant(P<0.05).The incidence of adverse pregnancy outcomes 14.00%of the observation group was obviously lower than 36.00%of the control group,and the difference was statistically significant(P<0.05).Conclusion The establishment of standardized pharmaceutical care process intervention in the treatment of hypertensive disorder complicating pregnancy can effectively control the blood pressure of patients with hypertensive disorder complicating pregnancy,improve the medication compliance of patients and reduce the occurrence of adverse pregnancy outcomes.